Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 9.78%200.97M | 9.18%188.75M | 3.53%185.68M | 6.75%716.85M | 6.65%185.17M | 8.94%183.06M | 4.70%172.87M | 8.86%179.35M | 4.31%671.52M | 5.81%173.63M |
| Cost of revenue | 9.55%144.91M | 7.42%136.36M | 4.73%133.72M | 8.98%515.71M | 7.93%132.14M | 10.59%132.28M | 9.15%126.95M | 11.15%127.68M | 6.03%473.23M | 5.39%122.43M |
| Gross profit | 10.38%56.05M | 14.07%52.38M | 0.56%51.96M | 1.44%201.14M | 3.59%53.03M | 4.87%50.78M | -5.88%45.92M | 3.59%51.67M | 0.43%198.29M | 6.81%51.19M |
| Operating expense | 15.34%38.29M | 29.52%33.17M | 67.28%32.26M | 0.16%135.8M | 0.88%36.42M | -6.47%33.2M | -10.48%25.61M | -34.53%19.29M | 16.06%135.59M | 32.62%36.1M |
| Selling and administrative expenses | 16.87%39.67M | 23.60%36.1M | 0.85%33.28M | 0.16%135.8M | 0.88%36.42M | -4.36%33.95M | -7.24%29.21M | 1.30%33M | 16.06%135.59M | 32.62%36.1M |
| -General and administrative expense | 16.87%39.67M | 23.60%36.1M | 0.85%33.28M | 0.16%135.8M | 0.88%36.42M | -4.36%33.95M | -7.24%29.21M | 1.30%33M | 16.06%135.59M | 32.62%36.1M |
| Total other operating income | 84.91%1.39M | -18.53%2.93M | -92.56%1.02M | ---- | ---- | --749K | 25.00%3.6M | 339.87%13.72M | ---- | ---- |
| Operating profit | 1.03%17.77M | -5.40%19.22M | -39.18%19.7M | 4.21%65.34M | 10.07%16.61M | 35.99%17.58M | 0.64%20.31M | 58.58%32.39M | -22.22%62.7M | -27.11%15.09M |
| Net non-operating interest income (expenses) | 6.00%-9.09M | -4.68%-9.42M | -9.04%-9.34M | -7.44%-36.73M | -3.05%-9.44M | -6.23%-9.67M | -10.67%-8.99M | -10.62%-8.56M | -27.18%-34.19M | -20.02%-9.16M |
| Non-operating interest expense | -6.00%9.09M | 4.68%9.42M | 9.04%9.34M | 7.12%36.56M | 3.05%9.44M | 6.23%9.67M | 10.67%8.99M | 10.62%8.56M | 26.94%34.12M | 20.02%9.16M |
| Total other finance cost | ---- | ---- | ---- | 172.31%177K | ---- | ---- | ---- | ---- | --65K | ---- |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | -415.15%-104K | 92.55%-7K | 2,225.00%93K | -85.71%42K | -38.85%277K | 145.21%33K | -161.11%-94K | 108.00%4K | 153.94%294K | 400.00%453K |
| Special income (charges) | 1,334.38%1.84M | 527.82%569K | -95.98%16K | -62.48%577K | -104.68%-40K | -75.71%128K | -3,225.00%-133K | 147.20%398K | 138.45%1.54M | 173.72%854K |
| Less:Write off | -1,334.38%-1.84M | -527.82%-569K | 95.98%-16K | 62.48%-577K | 104.68%40K | 75.71%-128K | 3,225.00%133K | -147.20%-398K | -138.45%-1.54M | -173.72%-854K |
| Other non-operating income (expenses) | 84.91%1.39M | -44.94%19.58M | -77.21%771K | -97.14%749K | 320.85%35.56M | 6,605.77%3.38M | ||||
| Income before tax | 28.87%10.41M | -6.57%10.36M | -56.78%10.47M | -25.94%48.8M | -22.97%8.19M | -73.48%8.08M | -7.70%11.09M | 89.37%24.23M | 5.81%65.9M | -19.41%10.63M |
| Income tax | 41.28%2.83M | 25.62%2.69M | -4.29%2.7M | 177.81%7.65M | 168.54%2.35M | 19.75%2M | 10.24%2.14M | 10.23%2.82M | -78.92%2.75M | -195.78%-3.42M |
| Net income | 24.79%7.58M | -14.28%7.67M | -63.71%7.77M | -34.82%41.16M | -58.43%5.84M | -78.89%6.08M | -11.16%8.95M | 109.18%21.4M | 28.30%63.15M | 46.17%14.05M |
| Net income continuous operations | 24.79%7.58M | -14.28%7.67M | -63.71%7.77M | -34.82%41.16M | -58.43%5.84M | -78.89%6.08M | -11.16%8.95M | 109.18%21.4M | 28.30%63.15M | 46.17%14.05M |
| Noncontrolling interests | 44.74%440K | 49.84%923K | 111.15%549K | -5.87%1.33M | 44.96%819K | -23.43%304K | 75.50%616K | 157.43%260K | 94.77%1.41M | 67.66%565K |
| Net income attributable to the company | 23.74%7.14M | -19.02%6.75M | -65.86%7.22M | -35.49%39.82M | -62.77%5.02M | -79.67%5.77M | -14.29%8.33M | 108.70%21.14M | 27.30%61.73M | 45.39%13.49M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 23.74%7.14M | -19.02%6.75M | -65.86%7.22M | -35.49%39.82M | -62.77%5.02M | -79.67%5.77M | -14.29%8.33M | 108.70%21.14M | 27.30%61.73M | 45.39%13.49M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 26.15%0.0082 | -18.95%0.0077 | -65.83%0.0082 | -35.52%0.0452 | -45.71%0.0057 | -79.81%0.0065 | -35.81%0.0095 | 108.70%0.024 | 28.15%0.0701 | 0.00%0.0105 |
| Diluted earnings per share | 26.15%0.0082 | -18.95%0.0077 | -65.83%0.0082 | -35.57%0.0451 | -45.71%0.0057 | -79.81%0.0065 | -35.81%0.0095 | 108.70%0.024 | 27.97%0.07 | 0.00%0.0105 |
| Dividend per share | 0.00%0.008 | 0 | 0.00%0.008 | -11.11%0.016 | 0 | 0.00%0.008 | 0 | -20.00%0.008 | -35.71%0.018 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.